CS logo
small CS logo
The First Affiliated Hospital of Shantou University Medical College

Shantou, Guangdong, China
Hospital in Shantou
Guangdong Province, Shantou, Jinping District, Dongxia N Rd, 东夏北路 邮政编码 - 515051

About The First Affiliated Hospital of Shantou University Medical College


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
6
Pfizer
3
Beijing Tiantan Hospital
1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
1
Lepu Medical Technology (Beijing) Co., Ltd.
1
Mundipharma (China) Pharmaceutical Co. Ltd
1
Nanjing Medical University
1
Sixth Affiliated Hospital, Sun Yat-sen University
1
Sun Yat-sen University
1
Sunshine Lake Pharma Co., Ltd.
1
Takeda
1
Total Rows: 12

Clinical Trials at The First Affiliated Hospital of Shantou University Medical College


During the past decade, The First Affiliated Hospital of Shantou University Medical College conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 6 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11110033223333330000000000002233Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
2010-08-01
2012-12-01
Completed
416
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
2013-06-27
2020-11-12
Completed
2,877
Targin for Non-cancer Pain
2013-09-01
2017-03-30
Completed
230
Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(ALTER0303)
2015-02-26
2017-01-06
Completed
439
A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.
2018-04-05
2023-02-23
Completed
421
A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus
2018-03-22
2020-03-18
Completed
536
A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus
2018-03-23
2020-03-05
Completed
272
Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria
2020-12-25
2023-01-23
Terminated
15

Rows per page:

1–19 of 19

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "The First Affiliated Hospital of Shantou University Medical College" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Pfizer" with 3 trials sponsored, "Beijing Tiantan Hospital" with 1 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored and "Lepu Medical Technology (Beijing) Co., Ltd." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The First Affiliated Hospital of Shantou University Medical College" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Amylin Pharmaceuticals, LLC." with 1 trials as a collaborator, "Beijing Anzhen Hospital" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 6Eli Lilly and Company: 6Pfizer: 3Pfizer: 3Beijing Tiantan Hospital: 1Beijing Tiantan Hospital: 1Chia Tai TianqingPharmaceutical GroupCo., Ltd.: 1Chia Tai TianqingPharmaceutical GroupCo., Ltd.: 1Lepu MedicalTechnology (Beijing)Co., Ltd.: 1Lepu MedicalTechnology (Beijing)Co., Ltd.: 1Mundipharma (China)Pharmaceutical Co. Ltd:1Mundipharma (China)Pharmaceutical Co. Ltd:1Nanjing Medical University: 1Nanjing Medical University: 1Sixth Affiliated Hospital,Sun Yat-sen University:1Sixth Affiliated Hospital,Sun Yat-sen University:1Sun Yat-sen University: 1Sun Yat-sen University: 1Sunshine Lake PharmaCo., Ltd.: 1Sunshine Lake PharmaCo., Ltd.: 1

Created with Highcharts 11.1.0Top CollaboratorsAllergan: 1Allergan: 1Amylin Pharmaceuticals, LLC.: 1Amylin Pharmaceuticals, LLC.: 1Beijing Anzhen Hospital: 1Beijing Anzhen Hospital: 1Biomedical AdvancedResearch andDevelopment Authority:1Biomedical AdvancedResearch andDevelopment Authority:1Eli Lilly and Company: 1Eli Lilly and Company: 1Innovative MedicinesInitiative (IMI)COMBACTE-CARE (EU):1Innovative MedicinesInitiative (IMI)COMBACTE-CARE (EU):1Ministry of Health, China: 1Ministry of Health, China: 1Ministry of Science andTechnology of thePeople´s Republic ofChina: 1Ministry of Science andTechnology of thePeople´s Republic ofChina: 1Nicoya Therapeutics(Shanghai) Co., Ltd.: 1Nicoya Therapeutics(Shanghai) Co., Ltd.: 1

Clinical Trials Conditions at The First Affiliated Hospital of Shantou University Medical College


According to Clinical.Site data, the most researched conditions in "The First Affiliated Hospital of Shantou University Medical College" are "Rheumatoid Arthritis" (2 trials), "Aortic Aneurysm" (1 trials), "Aortic Dissection" (1 trials), "Arthritis" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "The First Affiliated Hospital of Shantou University Medical College" in a lesser frequency.

Clinical Trials Intervention Types at The First Affiliated Hospital of Shantou University Medical College


Most popular intervention types in "The First Affiliated Hospital of Shantou University Medical College" are "Drug" (16 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "ATM-AVI" (2 trials), "Insulin Lispro" (2 trials), "LY2963016" (2 trials) and "Lantus®" (2 trials). Other intervention names were less common.

Clinical Trials Genders at The First Affiliated Hospital of Shantou University Medical College


The vast majority of trials in "The First Affiliated Hospital of Shantou University Medical College" are 19 trials for "All" genders.

Clinical Trials Status at The First Affiliated Hospital of Shantou University Medical College


Currently, there are NaN active trials in "The First Affiliated Hospital of Shantou University Medical College". 3 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 12 completed trials in The First Affiliated Hospital of Shantou University Medical College, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The First Affiliated Hospital of Shantou University Medical College, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11Phase 2: 3Phase 2: 3Not Applicable: 2Not Applicable: 2Phase 1: 1Phase 1: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 12Completed: 12Not yet recruiting: 3Not yet recruiting: 3Recruiting: 2Recruiting: 2Enrolling by invitation: 1Enrolling by invitation: 1Terminated: 1Terminated: 1